INS and type 2 diabetes mellitus: In patients with T2DM and dementia, the use of metformin and DDP-4i was associated with a slower decline in MMSE scores, suggesting potential cognitive benefits. However, the use of insulin and SUs was associated with larger cognitive declines over time compared to DDP-4i.